Product NDC: | 43063-277 |
Proprietary Name: | spironolactone |
Non Proprietary Name: | spironolactone |
Active Ingredient(s): | 50 mg/1 & nbsp; spironolactone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 43063-277 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012151 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19600121 |
Package NDC: | 43063-277-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-277-30) |
NDC Code | 43063-277-30 |
Proprietary Name | spironolactone |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-277-30) |
Product NDC | 43063-277 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | spironolactone |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19600121 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | SPIRONOLACTONE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |